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 To the Editor, 
 C-reactive protein (CRP) is an acute phase protein with a 
known affinity for phospholipids (PLs). Phosphatidylcho-
line (PC) is the principal CRP ligand, but CRP also inter-
feres with other PL, e.g., phosphatidylethanolamine (PE) 
 [1 – 3] . Recently, we illustrated that CRP interferes with 
activated partial thromboplastin time (aPTT), prolonging 
clotting times (CT) proportionally with CRP concentration 
 [4] and depending on the type of aPTT reagent  [4, 5] . PLs 
act as catalytic surfaces in clotting assays such as aPTT, 
hence this phenomenon is most likely PL-dependent, with 
both concentration and type of PL taking part. To unravel 
the mechanism, we studied the influence of CRP on differ-
ent aPTT reagents. To work in PL-controlled conditions, 
we performed thrombin generation (TG) measurements by 
calibrated automated thrombinography (CAT  ®  ; Thrombi-
noscope, Maastricht, The Netherlands)  [6] . We compared 
the results with the effect on thrombin time, a PL-inde-
pendent clotting time (CT). Moreover, we compared the 
effect of CRP with that of annexin V (AnV), a potent 
endothelial surface anticoagulant based on its ability to 
displace PL-dependent coagulation factors by binding to 
negatively charged PL, including phosphatidylserine (PS) 
and PE  [1, 7] . We attempted to visualize the binding of CRP 
to the PL surface by flow cytometry. Finally, we measured 
the PC content and the surface tension of the reagents 
because differences in interference of CRP may be deter-
mined by the accessibility of PL. 
 Platelet-poor normal pooled plasma (NPP) was spiked 
with CRP or AnV and tested in duplicate on STAR-Evolu-
tion (Diagnostica Stago, Asni è res, France) with different 
aPTT reagents and thrombin time. The reagents are listed 
in Table 1 in Supplemental Material. Only limited informa-
tion on the type and concentration of PL in these reagents 
was provided by the manufacturer. 
 We used purified CRP prepared as described pre-
viously  [8] to obtain a dilution series with a final CRP 
concentration of 0, 25, 50, 100, 150, 200, and 300 mg/L. 
The final concentration range of AnV (Sigma-Aldrich, St. 
Louis, MO, USA) (0 – 0.09 – 0.18 – 0.36 – 0.72 – 1.14  μ M) was 
based on current literature  [7] . 
 TG was triggered in platelet-poor plasma by tissue 
factor (TF, 5 pM) or silica (a 1/400 diluted aPTT reagent, 
PTT-A; Diagnostica Stago) and PL (4  μ M). The CAT was 
performed as reported previously  [6, 9] . Under these con-
ditions, TG is PL-controlled, allowing to perform the test 
with different PLs separately: PE, PC, PS in purified linear 
structure (Sigma-Aldrich) and hexagonal PL (PE) of Sta-
clot-LA (Diagnostica Stago) (HPE). Mixtures of PC and PS 
were used in a 70/30, 50/50, 30/70, 0/100, and 100/0 pro-
portion. The concentration of HPE in Staclot-LA reagent 
was not revealed by the manufacturer and was therefore 
used in different dilutions (1/10, 1/50, and 1/100). 
 To evaluate the prolongation of the lag time (LT) and 
the reduction of the peak height (PH), TG parameters were 
coupled in a PH/LT ratio  [9] . 
 Microparticles (MPs) were prepared by activating 
platelets with calcium ionophore (Sigma-Aldrich). Flow 
cytometric analysis of MP on FACSCanto II (Becton Dick-
inson, Erembodegem, Belgium) was performed with AnV 
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(eBioscience, San Diego, CA, USA) and CD41 (Analis/
Beckman Coulter, Suarl é e, Belgium) as described pre-
viously  [10] . As competition between CRP and AnV for 
binding to PL was presumed, the strength of AnV staining 
of the MP in relation to the CRP concentration was studied. 
Furthermore, in an attempt to visualize MP-bound CRP, 
CRP was labeled with FITC (Sigma-Aldrich). In addition, 
FITC-labeled anti-CRP (Abcam, Cambridge, UK) was used 
in parallel with anti-IgG1-FITC functioning as an isotypic 
control (Sigma-Aldrich). 
 Surface tension of the reagents was measured using 
the Wilhelmy plate method  [11] . All measurements were 
performed in duplicate. PC was measured using the 
LabAssay ™ Phospholipid (Wako, Neuss, Germany), 
an enzymatic assay using  N -ethyl- N -(2-hydroxy-3-
sulfopropy)-3,5-domethoxyaniline  [12] . 
 Our spiking experiments confirmed that prolongation 
of aPTT through CRP is dose- and reagent-dependent  [4, 
5] . CTs were prolonged with all aPTT reagents (mean pro-
longation 64.1%, range 33.2% – 99.2%) with increasing CRP 
concentrations but not with thrombin time (see  Table 1 ). 
The two silica-based reagents frequently used in lupus 
anticoagulant (LAC) detection showed high sensitivity 
for CRP interference: we observed an aPTT prolongation 
of more than 20% from 25 to 50 mg/L on for Staclot-LA 
PTT-LS (buffer) and PTT-LA, respectively. Staclot-LA 
PTT-LS with excess of HPE used as a confirmation test in 
LAC did not show a prolongation, thus matching with the 
mechanism of aPTT prolongation by LAC due to competi-
tion of coagulation factors on negatively charged PL  [4, 13, 
14] . Cephascreen showed prolongation from 50 mg/L on 
and showed the most strongly prolonged aPTT (up to 120% 
for 175  mg/L CRP). All other reagents showed prolonga-
tion from 100 mg/L CRP on. As expected, thrombin time, 
a PL-independent coagulation test, was not influenced by 
CRP. A similar pattern of prolongation was observed for 
increasing concentrations of AnV ( Table 2 ), supporting 
the idea that prolongation of CT in PL-dependent assays 
by CRP is based on binding to negatively charged PL. 
 To evaluate the influence on TG parameters, coef-
ficients of variation (CVs, %) were calculated for NPP 
not spiked with CRP in all methodological conditions. 
Based on the maximal between-run CVs for PH/LT in test 
methods with PC, PS, and PE with silica and TF (28.5% 
and 17.6%, respectively) and in the test methods with 
HPE with silica and TF (55.6% and 22.2%, respectively), 
cutoffs for normalized PH/LT were set at 0.72, 0.82, 0.44, 
and 0.78, respectively. TG performed with PC, PS, PE, and 
variable PC/PS ratios (all 4  μ M final concentration), and 
both reaction triggers were not significantly decreased 
with increasing CRP concentrations (0 – 300 mg/L CRP) 
(see  Figure 1 A and B). TG performed with HPE was more 
 Table 1   Results of the CTs of NPP spiked with increasing CRP concentrations. 
Reagent 
 
 
 
CRP, mg/L 
0.0 a (1.0) b   25.0 (38.4) b   50.0 (78.7) b   100.0 (165.2) b   150.0 (251.7) b   175.0 (302.2) b   200.0 (323.2) b 
PTT-A   1.0  1.1  1.1  1.5  1.6  1.7  1.6
C.K. Prest   1.0  1.0  1.1  1.5  1.7  1.7  1.6
Cephascreen   1.0  1.1  1.3  1.9  2.1  2.2  2.0
Actin   1.0  1.0  1.1  1.4  1.6  1.7  1.9
Actin FS   1.0  1.1  1.1  1.6  1.8  1.9  1.9
Actin FSL   1.0  1.0  1.1  1.2  1.4  1.4  1.5
Pathromtin SL   1.0  1.0  1.1  1.5  1.6  1.6  1.6
SynthASil   1.0  1.0  1.0  1.2  1.4  1.3  1.3
APTT-SP   1.0  1.0  1.0  1.6  1.7  1.6  1.7
PTT-LA   1.0  1.1  1.2  1.4  1.5  1.5  1.6
Staclot LA (PTT-LS)
   With excess HPE c   1.0  1.0  1.0  1.0  1.0  1.1  1.1
   With buffer   1.0  1.2  1.3  1.4  1.5  1.5  1.5
Thrombin time   1.0   1.0   1.0   1.1   1.1   1.1    – 
 a The sample with 0 concentration was prepared by adding an equal volume of the native elution fluid to the NPP. Addition of a small volume 
of solution ( < 10% of total volume) was allowed without influence on CT by dilution effect.  b Final CRP concentration measured in the spiked 
NPP through a particle enhanced immunoturbidimetric assay (CRPLX; Roche Diagnostics, Mannheim, Germany).  c Test principle of Staclot-LA 
 – a LAC-sensitive aPTT reagent (PTT-LS) is used, and aPTT is performed twice, with addition of buffer (neutral) and with addition of excess 
of HPE. The experiments were performed with two different lots and all measurements were performed in duplicate. Only data for one lot of 
reagent are shown. The results are expressed as normalized ratios: CT of NPP spiked with CRP divided by the CT of the NPP without added 
CRP. 
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sensitive to interference of CRP, at least at higher concen-
trations. A slight decrease (normalized ratio PH/LT 0.78) 
was observed from a CRP concentration of 150 mg/L on 
for TG triggered with TF and PE. TG with HPE diluted 1/10 
showed a reduced PH/LT from 25 mg/L CRP on. CRP did 
not affect TG with higher dilution of HPE (1/50 and 1/100) 
(see  Figure 1 C and D). Corresponding with former find-
ings, TG with HPE showed a decreased normalized PH/LT 
 Table 2   Results of the CTs of NPP spiked with increasing AnV 
concentrations. 
Reagent  
 
AnV,  μ M 
0.00  0.09  0.18  0.36  0.72  1.44
PTT-A   1.0  1.0  1.0  1.1  1.3  1.6
PTT-LA   0.9  0.9  1.0  1.1  1.7  3.4
SynthASil   0.9  0.9  1.0  1.4  3.2  4.0
Staclot LA (PTT-LS)           
   With excess HPE   1.0  1.0  1.0  1.0  1.0  1.0
   With buffer   1.0   1.0   1.1   1.2   1.6   2.3 
 The results are expressed as normalized ratios: CT of NPP spiked 
with AnV divided by the CT of the NPP without added AnV. 
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 Figure 1   Relation between normalized PH/LT and concentration of CRP. 
 TG parameters were normalized by dividing the results for the samples spiked with CRP and those measured for the NPP not enriched with CRP. 
ratio starting from 24 mg/L CRP on, whereas for all other 
PL tested, TG showed no decrease in normalized PH/LT 
ratio at any CRP concentration  [4] . These TG experiments 
suggest that not the type of PL but the conformation 
(linear vs. hexagonal structure) plays a role in interference 
by CRP, supporting the complex mechanism of CRP and 
PL interaction that can be influenced by the conformation 
of the PL  [15] . Examples of TG curves are shown in Figure 1 
in the Supplemental Material. 
 No competition of binding of AnV with CRP could be 
demonstrated by flow cytometric experiments. Binding 
of CRP to the MP could not be objectified as a reduced 
AnV-CD41-intensity (see Supplemental Material, Figure 2). 
AnV expression on MP did not decrease in the presence 
of increasing concentrations of CRP. Probably, AnV binds 
more strongly, compared with CRP, to the MP surface. By 
labeling CRP with FITC, no FITC staining of the MP was 
observed, nor could binding of CRP to the MP be demon-
strated using FITC-labeled anti-CRP (data not shown). 
 Clotting assay reagents are mixtures of activators, 
PL, and non-specified additives. The large CRP molecule 
(105 kDa) may be hampered for binding on the PL depending 
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on the surface tension of the liquid. The surface tension for 
the aPTT reagents ranged from 38.8 to 71.9 mN/m. A mod-
erate correlation (Pearson correlation coefficient R = – 0,58) 
was found between the surface tension and the extent of CT 
prolongation (see  Figure 2 A): the higher the surface tension, 
the less the CRP-dependent prolongation of the CT, sugges-
tive of a steric hindrance of the large CRP molecule toward 
binding to the PL in the reagent. 
 We found a good correlation (R = 0.73) between the 
aPTT prolongation and the PL content of the reagents 
(see  Figure 2 B). The PC concentration ranged from 150 to 
241 mg/dL. The high value measured in the CK Prest 
reagent (2331 mg/L) was excluded. 
 In conclusion, the in vitro interaction of CRP with PL-
dependent CTs is complex. Nonetheless, we demonstrated 
through the similar action of AnV compared with CRP that 
the mechanism of prolongation of the PL-dependent CT is 
based on binding to negatively charged PL. The interac-
tion is not only influenced by the type of PL but rather by 
the conformation and the concentration of PL. Moreover, 
the variation in surface tension suggests that the overall 
constitution of the reagent plays a role in the CRP-depend-
ent prolongation of the CT. 
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 Figure 2   Correlation of aPTT-CT prolongation with the surface tension (A) and phosphatidyl choline concentration (B). 
 The percentage of aPTT-CT prolongation is expressed as a ratio of aPTT with the highest concentration of CRP to aPTT without CRP. 
(A) A moderate correlation exists between the surface tension of the reagents and the aPTT correlation. (B) A good correlation exists 
between the PL content of the reagent and the aPTT prolongation. 
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